Lexeo Therapeutics Inc. C...

AI Score

XX

Unlock

3.46
-0.64 (-15.61%)
At close: Mar 31, 2025, 3:59 PM
3.43
-0.92%
After-hours: Mar 31, 2025, 07:59 PM EDT

Lexeo Therapeutics Common Stock Ratios Statement

Year FY24 FY23 FY22 FY21 FY20
PE Ratio -2.13 -5.39 -4.18 -4.9 -48.11
PEG Ratio -0.09 -1.44 -0.24 -0.01 n/a
PS Ratio n/a n/a 379.08 149.62 478.17
PB Ratio 1.79 3.15 -2.19 -4.46 -44.78
P/FCF Ratio -2.56 -5.99 -4.47 -5.59 -79.12
P/OCF Ratio -2.58 -6.01 -4.54 -5.61 -79.12
OCF/S Ratio n/a n/a -83.43 -26.66 -6.04
Debt / Equity Ratio 0.08 0.10 -0.12 n/a -0.54
Quick Ratio 5.52 7.21 5.58 18.35 42.15
Current Ratio 5.52 7.21 5.58 18.35 42.15
Asset Turnover n/a n/a 0.01 0.01 0.02
Interest Coverage n/a -334.21 -664.93 n/a -31.18
Return on Equity (ROE) -0.84 -0.58 0.52 0.91 0.93
Return on Assets (ROA) -0.67 -0.47 -0.61 -0.37 -0.18
Return on Capital (ROIC) n/a -0.56 -0.73 -0.39 -0.16
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a -75.08% 99.19% 100.00%
Net Profit Margin n/a n/a -9.06K% -3.06K% -993.83%
Pretax Profit Margin n/a n/a -9.06K% -3.06K% -993.83%
Operating Profit Margin n/a n/a -9.25K% -3.06K% -884.86%
FCF Margin n/a n/a -8.48K% -2.68K% -604.35%
EBITDA Margin n/a n/a -8.87K% -3.06K% -884.04%